(−)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid protect against high glucose and lipopolysaccharide-induced inflammation in renal proximal tubular cells through NOX-4/p38 signalling

Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease. Epicatechin (EC) and main colonic phenolic acids derived from flavonoid intake, such as 2,3-dihydroxybenzoic acid (DHBA), 3,4-dihydroxyphenylacetic aci...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Food & function 2020-10, Vol.11 (1), p.8811-8824
Hauptverfasser: Álvarez Cilleros, David, López-Oliva, María Elvira, Martín, María Ángeles, Ramos, Sonia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 8824
container_issue 1
container_start_page 8811
container_title Food & function
container_volume 11
creator Álvarez Cilleros, David
López-Oliva, María Elvira
Martín, María Ángeles
Ramos, Sonia
description Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease. Epicatechin (EC) and main colonic phenolic acids derived from flavonoid intake, such as 2,3-dihydroxybenzoic acid (DHBA), 3,4-dihydroxyphenylacetic acid (DHPAA) and 3-hydroxyphenylpropionic acid (HPPA), have been suggested to exert beneficial effects in diabetes. This study was aimed at investigating whether the mentioned compounds could prevent inflammation in renal proximal tubular NRK-52E cells induced by high glucose and lipopolysaccharide (LPS). Pre-treatment of cells with EC and DHBA (5 μM) reverted the enhanced levels of pro-inflammatory cytokines, such as tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6) and monocyte chemoattractant protein 1 (MCP-1), activated by high glucose and LPS. Additionally, EC and DHBA pre-incubation reduced the increased values of adhesion molecules, namely, intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), as well as those of mitogen-activated protein kinases (MAPKs) [extracellular signal-regulated kinase (ERK), -c-jun N-terminal kinase (JNK) and -p38 protein kinase (p38)] activated by the high glucose and LPS challenge. Thus, in EC and DHBA pre-treated cells ICAM-1, p-ERK and p-JNK were returned to control values, and VCAM-1 and p-p38 levels were reduced by ∼20 and 25%, respectively, when compared to high glucose plus LPS-stimulated cells. Likewise, pre-treatment with EC and DHBA protected against high glucose plus LPS-triggered oxidative stress by preventing increased ROS and NADPH oxidase 4 (NOX-4) levels (∼25 and 45% reduction, respectively). By using specific inhibitors of p38 and NOX-4, the participation of both proteins in EC- and DHBA-mediated protection against inflammation and associated oxidative stress was shown. Taken together, EC and DHBA exert beneficial effects in renal proximal tubular cells, as they contribute to preventing the inflammatory-induced milieu and the accompanying redox imbalance, playing NOX-4/p38 a crucial role. Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease.
doi_str_mv 10.1039/d0fo01805h
format Article
fullrecord <record><control><sourceid>proquest_rsc_p</sourceid><recordid>TN_cdi_rsc_primary_d0fo01805h</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2452318685</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-ef55837775bb08c00323f9d062e86552210c92f9b0f7e478799dc70984c14d763</originalsourceid><addsrcrecordid>eNp9ksFuFSEUhidGY5vajXsNxk01jmVgGGBpamtNGu9Gk-4mDDAzNAxMgUl6fQLXPpdP4ZPI9LY1cSEbDvk__vycQ1E8r-D7CmJ-rGDvYcUgGR8V-wjWqGwIvHx8X9e82SsOY7yCeWHOGWdPiz2MOOGM8P3i19HvHz_flKezkSJpORoHhFMgjRpIb70zEkw6ic5bkzRA73CpzLhVwd9sO-2--6wLaRSYg8_XExCDMC4mMJphBINdpI_61tGa2c_ebqOQchTBKF0apxapFTCut2KaRDLe5QMI2gm7Ot6YKRdp6RYrApDa2piTBb9k7y-by7I-njED0QyZt8YNz4onvbBRH97tB8W3s9OvJ-flxebT55MPF6XMHUil7glhmFJKug4ymfuCcM8VbJBmDSEIVVBy1PMO9lTXlFHOlaSQs1pWtaINPiiOdr454_WiY2onE9d4wmm_xBbVdc0ohXhFX_-DXvkl5LwrRRCuWMNIpt7uKBl8jEH37Rzy28O2rWC7jrn9CM82t2M-z_DLO8ulm7R6QO-HmoEXOyBE-aD-_SdZf_U_vZ1Vj_8AXXS69A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2452318685</pqid></control><display><type>article</type><title>(−)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid protect against high glucose and lipopolysaccharide-induced inflammation in renal proximal tubular cells through NOX-4/p38 signalling</title><source>MEDLINE</source><source>Royal Society Of Chemistry Journals 2008-</source><creator>Álvarez Cilleros, David ; López-Oliva, María Elvira ; Martín, María Ángeles ; Ramos, Sonia</creator><creatorcontrib>Álvarez Cilleros, David ; López-Oliva, María Elvira ; Martín, María Ángeles ; Ramos, Sonia</creatorcontrib><description>Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease. Epicatechin (EC) and main colonic phenolic acids derived from flavonoid intake, such as 2,3-dihydroxybenzoic acid (DHBA), 3,4-dihydroxyphenylacetic acid (DHPAA) and 3-hydroxyphenylpropionic acid (HPPA), have been suggested to exert beneficial effects in diabetes. This study was aimed at investigating whether the mentioned compounds could prevent inflammation in renal proximal tubular NRK-52E cells induced by high glucose and lipopolysaccharide (LPS). Pre-treatment of cells with EC and DHBA (5 μM) reverted the enhanced levels of pro-inflammatory cytokines, such as tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6) and monocyte chemoattractant protein 1 (MCP-1), activated by high glucose and LPS. Additionally, EC and DHBA pre-incubation reduced the increased values of adhesion molecules, namely, intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), as well as those of mitogen-activated protein kinases (MAPKs) [extracellular signal-regulated kinase (ERK), -c-jun N-terminal kinase (JNK) and -p38 protein kinase (p38)] activated by the high glucose and LPS challenge. Thus, in EC and DHBA pre-treated cells ICAM-1, p-ERK and p-JNK were returned to control values, and VCAM-1 and p-p38 levels were reduced by ∼20 and 25%, respectively, when compared to high glucose plus LPS-stimulated cells. Likewise, pre-treatment with EC and DHBA protected against high glucose plus LPS-triggered oxidative stress by preventing increased ROS and NADPH oxidase 4 (NOX-4) levels (∼25 and 45% reduction, respectively). By using specific inhibitors of p38 and NOX-4, the participation of both proteins in EC- and DHBA-mediated protection against inflammation and associated oxidative stress was shown. Taken together, EC and DHBA exert beneficial effects in renal proximal tubular cells, as they contribute to preventing the inflammatory-induced milieu and the accompanying redox imbalance, playing NOX-4/p38 a crucial role. Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease.</description><identifier>ISSN: 2042-6496</identifier><identifier>EISSN: 2042-650X</identifier><identifier>DOI: 10.1039/d0fo01805h</identifier><identifier>PMID: 32959859</identifier><language>eng</language><publisher>England: Royal Society of Chemistry</publisher><subject>Acids ; Adhesion ; Blood Glucose - metabolism ; c-Jun protein ; Catechin - pharmacology ; Cell adhesion ; Cell adhesion &amp; migration ; Cell adhesion molecules ; Cell Culture Techniques ; Colon - metabolism ; Cytokines ; Diabetes ; Diabetes mellitus ; Diabetic Nephropathies - etiology ; Diabetic Nephropathies - prevention &amp; control ; Dihydroxybenzoic acid ; Dihydroxyphenylacetic acid ; Epicatechin ; Extracellular signal-regulated kinase ; Flavonoids ; Glucose ; Humans ; Hydroxybenzoates - pharmacology ; Hyperglycemia ; Inflammation ; Intercellular adhesion molecule 1 ; Interleukin 6 ; JNK protein ; Kidney diseases ; Kidney Tubules - cytology ; Kidney Tubules - drug effects ; Kinases ; Lipopolysaccharides ; Lipopolysaccharides - metabolism ; Metabolites ; Monocyte chemoattractant protein ; Monocyte chemoattractant protein 1 ; Monocytes ; NAD(P)H oxidase ; NADPH Oxidase 4 - metabolism ; Oxidative stress ; p38 Mitogen-Activated Protein Kinases - metabolism ; Pathogenesis ; Phenolic acids ; Phenols ; Pretreatment ; Protective Agents - pharmacology ; Protein kinase ; Proteins ; Signal Transduction - drug effects ; Transcription factors ; Tumor necrosis factor-TNF ; Tumors</subject><ispartof>Food &amp; function, 2020-10, Vol.11 (1), p.8811-8824</ispartof><rights>Copyright Royal Society of Chemistry 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-ef55837775bb08c00323f9d062e86552210c92f9b0f7e478799dc70984c14d763</citedby><cites>FETCH-LOGICAL-c399t-ef55837775bb08c00323f9d062e86552210c92f9b0f7e478799dc70984c14d763</cites><orcidid>0000-0003-2649-2616 ; 0000-0002-0615-9149</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32959859$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Álvarez Cilleros, David</creatorcontrib><creatorcontrib>López-Oliva, María Elvira</creatorcontrib><creatorcontrib>Martín, María Ángeles</creatorcontrib><creatorcontrib>Ramos, Sonia</creatorcontrib><title>(−)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid protect against high glucose and lipopolysaccharide-induced inflammation in renal proximal tubular cells through NOX-4/p38 signalling</title><title>Food &amp; function</title><addtitle>Food Funct</addtitle><description>Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease. Epicatechin (EC) and main colonic phenolic acids derived from flavonoid intake, such as 2,3-dihydroxybenzoic acid (DHBA), 3,4-dihydroxyphenylacetic acid (DHPAA) and 3-hydroxyphenylpropionic acid (HPPA), have been suggested to exert beneficial effects in diabetes. This study was aimed at investigating whether the mentioned compounds could prevent inflammation in renal proximal tubular NRK-52E cells induced by high glucose and lipopolysaccharide (LPS). Pre-treatment of cells with EC and DHBA (5 μM) reverted the enhanced levels of pro-inflammatory cytokines, such as tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6) and monocyte chemoattractant protein 1 (MCP-1), activated by high glucose and LPS. Additionally, EC and DHBA pre-incubation reduced the increased values of adhesion molecules, namely, intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), as well as those of mitogen-activated protein kinases (MAPKs) [extracellular signal-regulated kinase (ERK), -c-jun N-terminal kinase (JNK) and -p38 protein kinase (p38)] activated by the high glucose and LPS challenge. Thus, in EC and DHBA pre-treated cells ICAM-1, p-ERK and p-JNK were returned to control values, and VCAM-1 and p-p38 levels were reduced by ∼20 and 25%, respectively, when compared to high glucose plus LPS-stimulated cells. Likewise, pre-treatment with EC and DHBA protected against high glucose plus LPS-triggered oxidative stress by preventing increased ROS and NADPH oxidase 4 (NOX-4) levels (∼25 and 45% reduction, respectively). By using specific inhibitors of p38 and NOX-4, the participation of both proteins in EC- and DHBA-mediated protection against inflammation and associated oxidative stress was shown. Taken together, EC and DHBA exert beneficial effects in renal proximal tubular cells, as they contribute to preventing the inflammatory-induced milieu and the accompanying redox imbalance, playing NOX-4/p38 a crucial role. Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease.</description><subject>Acids</subject><subject>Adhesion</subject><subject>Blood Glucose - metabolism</subject><subject>c-Jun protein</subject><subject>Catechin - pharmacology</subject><subject>Cell adhesion</subject><subject>Cell adhesion &amp; migration</subject><subject>Cell adhesion molecules</subject><subject>Cell Culture Techniques</subject><subject>Colon - metabolism</subject><subject>Cytokines</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetic Nephropathies - etiology</subject><subject>Diabetic Nephropathies - prevention &amp; control</subject><subject>Dihydroxybenzoic acid</subject><subject>Dihydroxyphenylacetic acid</subject><subject>Epicatechin</subject><subject>Extracellular signal-regulated kinase</subject><subject>Flavonoids</subject><subject>Glucose</subject><subject>Humans</subject><subject>Hydroxybenzoates - pharmacology</subject><subject>Hyperglycemia</subject><subject>Inflammation</subject><subject>Intercellular adhesion molecule 1</subject><subject>Interleukin 6</subject><subject>JNK protein</subject><subject>Kidney diseases</subject><subject>Kidney Tubules - cytology</subject><subject>Kidney Tubules - drug effects</subject><subject>Kinases</subject><subject>Lipopolysaccharides</subject><subject>Lipopolysaccharides - metabolism</subject><subject>Metabolites</subject><subject>Monocyte chemoattractant protein</subject><subject>Monocyte chemoattractant protein 1</subject><subject>Monocytes</subject><subject>NAD(P)H oxidase</subject><subject>NADPH Oxidase 4 - metabolism</subject><subject>Oxidative stress</subject><subject>p38 Mitogen-Activated Protein Kinases - metabolism</subject><subject>Pathogenesis</subject><subject>Phenolic acids</subject><subject>Phenols</subject><subject>Pretreatment</subject><subject>Protective Agents - pharmacology</subject><subject>Protein kinase</subject><subject>Proteins</subject><subject>Signal Transduction - drug effects</subject><subject>Transcription factors</subject><subject>Tumor necrosis factor-TNF</subject><subject>Tumors</subject><issn>2042-6496</issn><issn>2042-650X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9ksFuFSEUhidGY5vajXsNxk01jmVgGGBpamtNGu9Gk-4mDDAzNAxMgUl6fQLXPpdP4ZPI9LY1cSEbDvk__vycQ1E8r-D7CmJ-rGDvYcUgGR8V-wjWqGwIvHx8X9e82SsOY7yCeWHOGWdPiz2MOOGM8P3i19HvHz_flKezkSJpORoHhFMgjRpIb70zEkw6ic5bkzRA73CpzLhVwd9sO-2--6wLaRSYg8_XExCDMC4mMJphBINdpI_61tGa2c_ebqOQchTBKF0apxapFTCut2KaRDLe5QMI2gm7Ot6YKRdp6RYrApDa2piTBb9k7y-by7I-njED0QyZt8YNz4onvbBRH97tB8W3s9OvJ-flxebT55MPF6XMHUil7glhmFJKug4ymfuCcM8VbJBmDSEIVVBy1PMO9lTXlFHOlaSQs1pWtaINPiiOdr454_WiY2onE9d4wmm_xBbVdc0ohXhFX_-DXvkl5LwrRRCuWMNIpt7uKBl8jEH37Rzy28O2rWC7jrn9CM82t2M-z_DLO8ulm7R6QO-HmoEXOyBE-aD-_SdZf_U_vZ1Vj_8AXXS69A</recordid><startdate>20201021</startdate><enddate>20201021</enddate><creator>Álvarez Cilleros, David</creator><creator>López-Oliva, María Elvira</creator><creator>Martín, María Ángeles</creator><creator>Ramos, Sonia</creator><general>Royal Society of Chemistry</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7T7</scope><scope>7TO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2649-2616</orcidid><orcidid>https://orcid.org/0000-0002-0615-9149</orcidid></search><sort><creationdate>20201021</creationdate><title>(−)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid protect against high glucose and lipopolysaccharide-induced inflammation in renal proximal tubular cells through NOX-4/p38 signalling</title><author>Álvarez Cilleros, David ; López-Oliva, María Elvira ; Martín, María Ángeles ; Ramos, Sonia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-ef55837775bb08c00323f9d062e86552210c92f9b0f7e478799dc70984c14d763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acids</topic><topic>Adhesion</topic><topic>Blood Glucose - metabolism</topic><topic>c-Jun protein</topic><topic>Catechin - pharmacology</topic><topic>Cell adhesion</topic><topic>Cell adhesion &amp; migration</topic><topic>Cell adhesion molecules</topic><topic>Cell Culture Techniques</topic><topic>Colon - metabolism</topic><topic>Cytokines</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetic Nephropathies - etiology</topic><topic>Diabetic Nephropathies - prevention &amp; control</topic><topic>Dihydroxybenzoic acid</topic><topic>Dihydroxyphenylacetic acid</topic><topic>Epicatechin</topic><topic>Extracellular signal-regulated kinase</topic><topic>Flavonoids</topic><topic>Glucose</topic><topic>Humans</topic><topic>Hydroxybenzoates - pharmacology</topic><topic>Hyperglycemia</topic><topic>Inflammation</topic><topic>Intercellular adhesion molecule 1</topic><topic>Interleukin 6</topic><topic>JNK protein</topic><topic>Kidney diseases</topic><topic>Kidney Tubules - cytology</topic><topic>Kidney Tubules - drug effects</topic><topic>Kinases</topic><topic>Lipopolysaccharides</topic><topic>Lipopolysaccharides - metabolism</topic><topic>Metabolites</topic><topic>Monocyte chemoattractant protein</topic><topic>Monocyte chemoattractant protein 1</topic><topic>Monocytes</topic><topic>NAD(P)H oxidase</topic><topic>NADPH Oxidase 4 - metabolism</topic><topic>Oxidative stress</topic><topic>p38 Mitogen-Activated Protein Kinases - metabolism</topic><topic>Pathogenesis</topic><topic>Phenolic acids</topic><topic>Phenols</topic><topic>Pretreatment</topic><topic>Protective Agents - pharmacology</topic><topic>Protein kinase</topic><topic>Proteins</topic><topic>Signal Transduction - drug effects</topic><topic>Transcription factors</topic><topic>Tumor necrosis factor-TNF</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Álvarez Cilleros, David</creatorcontrib><creatorcontrib>López-Oliva, María Elvira</creatorcontrib><creatorcontrib>Martín, María Ángeles</creatorcontrib><creatorcontrib>Ramos, Sonia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Food &amp; function</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Álvarez Cilleros, David</au><au>López-Oliva, María Elvira</au><au>Martín, María Ángeles</au><au>Ramos, Sonia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>(−)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid protect against high glucose and lipopolysaccharide-induced inflammation in renal proximal tubular cells through NOX-4/p38 signalling</atitle><jtitle>Food &amp; function</jtitle><addtitle>Food Funct</addtitle><date>2020-10-21</date><risdate>2020</risdate><volume>11</volume><issue>1</issue><spage>8811</spage><epage>8824</epage><pages>8811-8824</pages><issn>2042-6496</issn><eissn>2042-650X</eissn><abstract>Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease. Epicatechin (EC) and main colonic phenolic acids derived from flavonoid intake, such as 2,3-dihydroxybenzoic acid (DHBA), 3,4-dihydroxyphenylacetic acid (DHPAA) and 3-hydroxyphenylpropionic acid (HPPA), have been suggested to exert beneficial effects in diabetes. This study was aimed at investigating whether the mentioned compounds could prevent inflammation in renal proximal tubular NRK-52E cells induced by high glucose and lipopolysaccharide (LPS). Pre-treatment of cells with EC and DHBA (5 μM) reverted the enhanced levels of pro-inflammatory cytokines, such as tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6) and monocyte chemoattractant protein 1 (MCP-1), activated by high glucose and LPS. Additionally, EC and DHBA pre-incubation reduced the increased values of adhesion molecules, namely, intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), as well as those of mitogen-activated protein kinases (MAPKs) [extracellular signal-regulated kinase (ERK), -c-jun N-terminal kinase (JNK) and -p38 protein kinase (p38)] activated by the high glucose and LPS challenge. Thus, in EC and DHBA pre-treated cells ICAM-1, p-ERK and p-JNK were returned to control values, and VCAM-1 and p-p38 levels were reduced by ∼20 and 25%, respectively, when compared to high glucose plus LPS-stimulated cells. Likewise, pre-treatment with EC and DHBA protected against high glucose plus LPS-triggered oxidative stress by preventing increased ROS and NADPH oxidase 4 (NOX-4) levels (∼25 and 45% reduction, respectively). By using specific inhibitors of p38 and NOX-4, the participation of both proteins in EC- and DHBA-mediated protection against inflammation and associated oxidative stress was shown. Taken together, EC and DHBA exert beneficial effects in renal proximal tubular cells, as they contribute to preventing the inflammatory-induced milieu and the accompanying redox imbalance, playing NOX-4/p38 a crucial role. Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease.</abstract><cop>England</cop><pub>Royal Society of Chemistry</pub><pmid>32959859</pmid><doi>10.1039/d0fo01805h</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-2649-2616</orcidid><orcidid>https://orcid.org/0000-0002-0615-9149</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2042-6496
ispartof Food & function, 2020-10, Vol.11 (1), p.8811-8824
issn 2042-6496
2042-650X
language eng
recordid cdi_rsc_primary_d0fo01805h
source MEDLINE; Royal Society Of Chemistry Journals 2008-
subjects Acids
Adhesion
Blood Glucose - metabolism
c-Jun protein
Catechin - pharmacology
Cell adhesion
Cell adhesion & migration
Cell adhesion molecules
Cell Culture Techniques
Colon - metabolism
Cytokines
Diabetes
Diabetes mellitus
Diabetic Nephropathies - etiology
Diabetic Nephropathies - prevention & control
Dihydroxybenzoic acid
Dihydroxyphenylacetic acid
Epicatechin
Extracellular signal-regulated kinase
Flavonoids
Glucose
Humans
Hydroxybenzoates - pharmacology
Hyperglycemia
Inflammation
Intercellular adhesion molecule 1
Interleukin 6
JNK protein
Kidney diseases
Kidney Tubules - cytology
Kidney Tubules - drug effects
Kinases
Lipopolysaccharides
Lipopolysaccharides - metabolism
Metabolites
Monocyte chemoattractant protein
Monocyte chemoattractant protein 1
Monocytes
NAD(P)H oxidase
NADPH Oxidase 4 - metabolism
Oxidative stress
p38 Mitogen-Activated Protein Kinases - metabolism
Pathogenesis
Phenolic acids
Phenols
Pretreatment
Protective Agents - pharmacology
Protein kinase
Proteins
Signal Transduction - drug effects
Transcription factors
Tumor necrosis factor-TNF
Tumors
title (−)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid protect against high glucose and lipopolysaccharide-induced inflammation in renal proximal tubular cells through NOX-4/p38 signalling
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T01%3A11%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_rsc_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=(%E2%88%92)-Epicatechin%20and%20the%20colonic%20metabolite%202,3-dihydroxybenzoic%20acid%20protect%20against%20high%20glucose%20and%20lipopolysaccharide-induced%20inflammation%20in%20renal%20proximal%20tubular%20cells%20through%20NOX-4/p38%20signalling&rft.jtitle=Food%20&%20function&rft.au=%C3%81lvarez%20Cilleros,%20David&rft.date=2020-10-21&rft.volume=11&rft.issue=1&rft.spage=8811&rft.epage=8824&rft.pages=8811-8824&rft.issn=2042-6496&rft.eissn=2042-650X&rft_id=info:doi/10.1039/d0fo01805h&rft_dat=%3Cproquest_rsc_p%3E2452318685%3C/proquest_rsc_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2452318685&rft_id=info:pmid/32959859&rfr_iscdi=true